Nutriband (NTRB) files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for ...
A timely 2026 release highlighting growing consumer research interest in skin-absorption wellness formats, ingredient themes, ...
Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.
Purisaki Berberine Patches belong to this new category. These are patches that are meant to deliver ingredients slowly over ...
The US Food and Drug Administration (FDA) has approved a transdermal patch formulation of the atypical antipsychotic asenapine (Secuado, Noven Pharmaceuticals) for the treatment of adults with ...
FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization.
Nutriband Inc. has successfully completed the scale-up of the commercial manufacturing process for its lead product, Aversa™ Fentanyl, in partnership with Kindeva, a contract development and ...
A preclinical study commissioned by Alliqua, Inc. (OTCQB: ALQA) ("Alliqua" or "the Company") concluded that the Company's investigational lidocaine transdermal patch compares favorably to the Lidoderm ...
Patients and prescribers alike are familiar with the vast array of psychiatric medicines available to treat mental illnesses. They are often less aware that certain psychotropics can be delivered via ...
A bio-inspired dual-amplified patch (MN@EV/SC) was fabricated by integrating extracellular vesicle-loaded microneedles with a soft suction chamber for effective transdermal delivery. The MN@EV/SC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results